These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3261590)

  • 1. Suppression of human fibroblast proliferation by D-penicillamine and copper sulfate in vitro.
    Matsubara T; Hirohata K
    Arthritis Rheum; 1988 Aug; 31(8):964-72. PubMed ID: 3261590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.
    Lipsky PE
    J Clin Invest; 1984 Jan; 73(1):53-65. PubMed ID: 6606652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-penicillamine cooperates with copper sulfate to enhance the surface expression of functional Fas antigen in rheumatoid synovial fibroblasts via the generation of hydrogen peroxide.
    Harada S; Sugiyama E; Taki H; Shinoda K; Fujita T; Maruyama M; Kobayashi M
    Clin Exp Rheumatol; 2002; 20(4):469-76. PubMed ID: 12175101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
    Matsubara T; Saura R; Hirohata K; Ziff M
    J Clin Invest; 1989 Jan; 83(1):158-67. PubMed ID: 2463265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mitogen-induced response of human peripheral blood mononuclear cells by bucillamine, a new antirheumatic sulfhydryl drug.
    Akamatsu T; Matsubara T; Saegusa Y; Mizuno K
    Rheumatol Int; 1994; 13(5):197-201. PubMed ID: 8202663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro production and scavenging of hydrogen peroxide by D-penicillamine. Relationship to copper availability.
    Staite ND; Messner RP; Zoschke DC
    Arthritis Rheum; 1985 Aug; 28(8):914-21. PubMed ID: 4026887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose gold compounds inhibit fibroblast proliferation and do not affect interleukin-1 secretion by macrophages.
    Matsubara T; Saegusa Y; Hirohata K
    Arthritis Rheum; 1988 Oct; 31(10):1272-80. PubMed ID: 3140819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of D-penicillamine on mitogen-induced human lymphocyte proliferation: synergistic inhibition by D-penicillamine and copper salts.
    Lipsky PE; Ziff M
    J Immunol; 1978 Mar; 120(3):1006-13. PubMed ID: 632576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CuSO4 as an inhibitor of B cell proliferation.
    Yamauchi T; Yamamoto I
    Jpn J Pharmacol; 1990 Dec; 54(4):455-60. PubMed ID: 2087007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression by captopril in vitro: inhibition of human natural killer activity by copper-dependent generation of hydrogen peroxide.
    Sugiyama E; Iwata M; Yamashita N; Yoshikawa T; Maruyama M; Yano S
    Jpn J Med; 1986 May; 25(2):149-54. PubMed ID: 3528599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of human antibody production in vitro by D-penicillamine and CuSO4: inhibition of helper T cell function.
    Lipsky PE
    J Rheumatol Suppl; 1981; 7():69-73. PubMed ID: 6971939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of DNA strand breaks by D-penicillamine and bucillamine in human lymphocytes.
    Yamanaka H; Hakoda M; Kamatani N; Kashiwazaki S; Carson DA
    Immunopharmacology; 1993; 26(2):113-8. PubMed ID: 8282535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation.
    Starkebaum G; Root RK
    J Immunol; 1985 May; 134(5):3371-8. PubMed ID: 2984288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the effects of the antirheumatic drugs, bucillamine and D-penicillamine, on mitogen-induced proliferation of mouse spleen cells.
    Mita S; Matsunaga K
    Agents Actions; 1990 Jun; 30(3-4):363-8. PubMed ID: 2386109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation.
    Gupte A; Mumper RJ
    J Inorg Biochem; 2007 Apr; 101(4):594-602. PubMed ID: 17275091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril inhibits proliferation of human lung fibroblasts in culture: a potential antifibrotic mechanism.
    Nguyen L; Ward WF; Ts'ao CH; Molteni A
    Proc Soc Exp Biol Med; 1994 Jan; 205(1):80-4. PubMed ID: 8115354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritis.
    Lipsky PE
    Z Rheumatol; 1988; 47 Suppl 1():6-8. PubMed ID: 2975107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4.
    Lipsky PE; Ziff M
    J Clin Invest; 1980 May; 65(5):1069-76. PubMed ID: 6965944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the growth and metabolism of cells cultured from normal, sclerotic and rheumatoid connective tissue brought about by D-penicillamine and by sodium salicylate.
    Priestley GC
    J Invest Dermatol; 1980 Jun; 74(6):413-7. PubMed ID: 6445922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the denaturation of human gamma globulin by a mixture of D-penicillamine disulfide and copper. A possible mechanism of action of D-penicillamine in rheumatoid arthritis.
    Gerber DA
    Biochem Pharmacol; 1978 Feb; 27(4):469-72. PubMed ID: 75730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.